Guardant Health (GH) Stock Looks Rich Even With Cash Flow Upside

Simply Wall St.10-27 01:29

Guardant Health has delivered a very large 3 year share price gain, which puts fresh attention on whether the current market value lines up with the cash flows the business can realistically produce. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2678480118?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","is_english":true,"pubTime":"2026-10-27 01:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2678480118","market":"sg","top_or_hot":-1,"title":"Guardant Health (GH) Stock Looks Rich Even With Cash Flow Upside","media":"Simply Wall St.","content":"<div>\n<p>Guardant Health has delivered a very large 3 year share price gain, which puts fresh attention on whether the current market value lines up with the cash flows the business can realistically produce. ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-looks-rich-even-with-cash-flow-upsi\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guardant Health (GH) Stock Looks Rich Even With Cash Flow Upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuardant Health (GH) Stock Looks Rich Even With Cash Flow Upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-27 01:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-looks-rich-even-with-cash-flow-upsi><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Guardant Health has delivered a very large 3 year share price gain, which puts fresh attention on whether the current market value lines up with the cash flows the business can realistically produce. ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-looks-rich-even-with-cash-flow-upsi\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0320765992.SGD","symbol_name":"FTIF - Franklin Biotechnology Discovery A Acc SGD","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-looks-rich-even-with-cash-flow-upsi","article_id":"2678480118","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-looks-rich-even-with-cash-flow-upsi","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2678480118","pubTimestamp":1793035747,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Guardant Health has delivered a very large 3 year share price gain, which puts fresh attention on whether the current market value lines up with the cash flows the business can realistically produce. With both legal setbacks and product milestones in the spotlight, the key issue for investors is how those events feed into that cash flow picture.\n\nOver the past 3 years the stock has returned about 5.7x, which makes the pricing of Guardant Health increasingly reliant on what its future cash...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","SPHQ":"Invesco S&P 500 Quality ETF","BK4588":"碎股","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","EKG":"First Trust Nasdaq Lux Digital Health Solutions ETF","LFSC":"F/m Emerald Life Sciences Innovation ETF","BK4551":"寇图资本持仓","PTH":"Invesco Dorsey Wright Healthcare Momentum ETF","GNMX":"Corgi Genomics & Precision Medicine ETF","BK4196":"保健护理服务","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","GH":"Guardant Health Inc.","GNOM":"Global X Genomics & Biotechnology ETF","GDOC":"Goldman Sachs Future Health Care Equity ETF","BK4585":"ETF&股票定投概念","HELX":"Franklin Genomic Advancements ETF","FFOX":"FUNDX FUTURE FUND OPPORTUNITIES ETF","BK4535":"淡马锡持仓"},"translate_title":"尽管现金流上升，Guardant Health (GH) 股票看起来仍然很丰富","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"GDOC":0.6,"LFSC":0.6,"EKG":0.6,"PTH":0.6,"HELX":0.6,"GNOM":0.6,"SPHQ":0.9,"FFOX":0.6,"GH":1.5,"GNMX":0.6},"content_text":"Guardant Health has delivered a very large 3 year share price gain, which puts fresh attention on whether the current market value lines up with the cash flows the business can realistically produce. With both legal setbacks and product milestones in the spotlight, the key issue for investors is how those events feed into that cash flow picture.  Over the past 3 years the stock has returned about 5.7x, which makes the pricing of Guardant Health increasingly reliant on what its future cash generation can support. The patent ruling against Guardant Health and the earlier US$245m award may affect future margins and capital needs, since any change in IP access or required payments can alter the timing and scale of cash flows from its liquid biopsy portfolio. Prefer to judge Guardant Health on sales? See why Guardant Health's 19.2x P/S tells a different valuation story.  The issue now is whether the cash flows implied by Guardant Health's current share price are supported by what the Discounted Cash Flow (DCF) intrinsic value estimate suggests. To understand how Guardant Health's recent gains and legal headwinds compare with other companies tied to cancer diagnostics and treatment, review it alongside 34 healthcare AI stocks AdvertisementIs Guardant Health Still Cheap on Cash Flow? The Discounted Cash Flow (DCF) model here is based on the cash the business could return to shareholders over time. Guardant Health currently reports a latest twelve month free cash flow loss of about $233 million, so the valuation leans heavily on expectations that this cash burn eases and then flips into meaningful positive free cash flow. The 2 Stage Free Cash Flow to Equity framework assumes a sharp recovery phase, with projected free cash flow moving into positive territory and reaching the hundreds of millions of dollars by 2030 and beyond. Those growth estimates help explain why the DCF output sits meaningfully above the current share price of $169.08. The patent ruling in favor of TwinStrand Biosciences and the University of Washington helps explain why the price may still lag the cash flow outlook implied by the model. Find out what Guardant Health could be worth using our Discounted Cash Flow (DCF) estimate. The Guardant Health Narrative: What Would Justify Today's Price? Simply Wall St Narratives for Guardant Health pick up where the DCF puzzle leaves off. They spell out which expectations for Guardant Health's growth, margins and earnings would need to hold for the current valuation to look stretched or conservative. Each narrative ties a specific fair value to a clear storyline about the company's potential catalysts and key risks, so you can track over time which version of events appears to be taking shape on the Community page. Guardant Health splits opinion between investors who think the testing platform justifies more optimism and others who see expectations already running hot. Bull case: 15% undervalued \"Rapid integration of AI-powered clinical analytics and multi-omic profiling into Guardant's Smart Liquid Biopsy platform is creating new clinical applications, enhancing product utility and differentiation versus peers...\" Discover why this Narrative puts Guardant Health at 15% undervalued. Bear case: 12% overvalued \"Reliance on premium Medicare ADLT pricing for Shield at US$1,495 and very limited commercial reimbursement means any shift in payer mix toward commercial patients or slower than hoped contracting could compress Shield ASPs and limit revenue growth from screening...\" Explore why this Narrative puts Guardant Health at 12% overvalued. One more Guardant Health check that belongs beside the valuation work Before you stop at the share price and cash flow story, it is worth asking who is steering Guardant Health, how their rewards line up with your interests, and what that reveals about priorities. See who runs Guardant Health and how they are paid. This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2678480118","isCrawlerRequest":true}